Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.


Wilcox, MH, Rahav, G, Dubberke, ER et al. (7 more authors) (2019) Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II. Open Forum Infectious Diseases, 6 (8). ofz293. ISSN 2328-8957

Kelly, CP, Wilcox, MH, Glerup, H et al. (4 more authors) (2018) Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease. Gastroenterology, 155 (4). pp. 1270-1271. ISSN 0016-5085

Wilcox, MH, Gerding, DN, Poxton, IR et al. (18 more authors) (2017) Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. New England Journal of Medicine, 376 (4). pp. 305-317. ISSN 0028-4793

This list was generated on Sun Jul 5 05:04:34 2020 BST.